In this research, we found that ZNF267 was significantly upregulated in lymph node tissues of DLBCL patients, and the survival analysis showed that this upregulation could predict worse survival outcomes for DLBCL patients. This evidence concerns the gene ZNF267 and diffuse large B-cell lymphoma.